Supernus Pharmaceuticals, Inc. (SUPN)

Nasdaq Health Care Pharmaceuticals S&P SmallCap 600

$26.16

-0.58 (-2.17%)

Close of Nov 06, 2026 · end-of-day data

Source: Supernus Pharmaceuticals, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$215.00M	$302.24M	$408.90M	$392.75M	$520.40M	$579.77M	$667.24M	$607.52M	$661.82M	$718.95M
Cost of revenue	$11.99M	$15.21M	$15.36M	$16.66M	$52.46M	$75.06M	$87.22M	$83.78M	$77.91M	$74.56M
Gross profit	$203.02M	$287.02M	$393.54M	$376.10M	$467.94M	$504.71M	$580.02M	$523.74M	$583.91M	$644.39M
Research & development	$42.79M	$49.58M	$89.21M	$69.10M	$75.96M	$90.47M	$74.55M	$91.59M	$108.80M	$106.23M
Selling, general & admin	$106.01M	$137.91M	$154.70M	$153.25M	$200.68M	$304.76M	$377.22M	$336.36M	$321.58M	$485.56M
Operating income	$54.22M	$99.54M	$144.44M	$148.57M	$173.70M	$86.03M	$46.12M	-$5.27M	$81.67M	-$62.28M
Interest expense	$543.00K	$134.00K	$13.84M	$18.21M	$19.43M	$19.70M	$7.07M	$2.42M	$0	$0
Pre-tax income	$50.37M	$100.62M	$140.18M	$147.49M	$168.65M	$73.17M	$60.74M	$2.77M	$97.87M	-$49.03M
Income tax	-$40.85M	$43.33M	$29.18M	$34.43M	$41.70M	$19.75M	$32.00K	$1.45M	$24.00M	-$10.48M
Net income	$91.22M	$57.28M	$110.99M	$113.06M	$126.95M	$53.42M	$60.71M	$1.32M	$73.86M	-$38.55M
EBITDA	$56.62M	$107.67M	$151.51M	$155.23M	$191.84M	$118.62M	$131.67M	$79.59M	$162.08M	$29.28M
EPS (basic)	$1.84	$1.13	$2.13	$2.16	$2.41	$1.01	$1.13	$0.02	$1.34	$-0.68
EPS (diluted)	$1.76	$1.08	$2.05	$2.10	$2.36	$0.98	$1.04	$0.02	$1.32	$-0.68
Diluted shares	51.71M	53.30M	54.10M	53.82M	53.69M	54.36M	61.68M	55.51M	55.96M	56.45M
Gross margin	94.4%	95.0%	96.2%	95.8%	89.9%	87.1%	86.9%	86.2%	88.2%	89.6%
Operating margin	25.2%	32.9%	35.3%	37.8%	33.4%	14.8%	6.9%	-0.9%	12.3%	-8.7%
Net margin	42.4%	19.0%	27.1%	28.8%	24.4%	9.2%	9.1%	0.2%	11.2%	-5.4%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$66.40M	$100.30M	$192.25M	$181.38M	$288.64M	$203.43M	$93.12M	$75.05M	$69.33M	$128.45M
Short-term investments	$23.72M	$39.74M	$163.77M	$165.69M	$133.89M	$136.25M	$368.21M	—	—	—
Receivables	$41.53M	$65.59M	$102.92M	$87.33M	$140.88M	$148.93M	$165.50M	$144.16M	$142.08M	$187.80M
Inventory	$16.80M	$16.30M	$25.66M	$26.63M	$48.33M	$85.96M	$91.54M	$77.41M	$54.29M	$112.48M
Total current assets	$151.40M	$228.45M	$493.49M	$472.64M	$630.42M	$601.59M	$734.15M	$493.11M	$686.07M	$644.18M
Goodwill	—	—	—	$0	$77.91M	$117.52M	$117.02M	$117.02M	$117.02M	$124.88M
Total assets	$309.57M	$424.46M	$977.81M	$1.16B	$1.50B	$1.69B	$1.70B	$1.28B	$1.37B	$1.45B
Total current liabilities	$80.74M	$123.00M	$161.35M	$160.59M	$245.11M	$315.38M	$687.96M	$290.20M	$292.40M	$338.17M
Short-term debt	—	—	—	—	—	$0	—	—	—	—
Long-term debt	—	—	—	—	—	$379.25M	—	—	—	—
Total debt	—	—	—	—	—	$379.25M	—	—	—	—
Total liabilities	$117.81M	$156.98M	$524.79M	$564.85M	$759.24M	$873.30M	$816.30M	$356.16M	$332.34M	$390.93M
Shareholders' equity	$191.75M	$267.48M	$453.02M	$595.43M	$744.86M	$815.85M	$886.20M	$921.52M	$1.04B	$1.06B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$66.81M	$114.64M	$128.99M	$143.13M	$138.40M	$127.13M	$116.83M	$111.08M	$171.95M	$47.33M
Capital expenditures	$1.60M	$2.03M	$844.00K	$2.74M	$3.45M	—	$412.00K	$551.00K	$725.00K	$1.34M
Free cash flow	$65.21M	$112.61M	$128.14M	$140.39M	$134.95M	$127.13M	$116.41M	$110.53M	$171.23M	$45.99M
Investing cash flow	-$35.96M	-$86.42M	-$413.48M	-$157.92M	-$34.70M	-$81.91M	-$216.66M	$268.73M	-$189.87M	$4.11M
Financing cash flow	$2.05M	$5.68M	$376.44M	$3.93M	$3.56M	-$130.42M	-$10.48M	-$397.88M	$12.19M	$9.13M
Stock-based compensation	$5.93M	$8.43M	$11.29M	$14.85M	$16.56M	$17.91M	$17.57M	$26.76M	$27.75M	$33.05M
Depreciation & amortization	$2.40M	$8.13M	$7.06M	$6.66M	$18.14M	$32.59M	$85.54M	$84.86M	$80.41M	$91.56M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$164.31M	$143.64M	$168.32M	$175.69M	$174.16M	$149.82M	$165.45M	$192.10M	$211.57M	$207.71M	$219.06M	$226.77M
Cost of revenue	$19.63M	$16.31M	$17.92M	$17.58M	$26.10M	$15.76M	$16.83M	$18.96M	$23.01M	$23.39M	$33.67M	$27.02M
Gross profit	$144.69M	$127.33M	$150.41M	$158.11M	$148.06M	$134.06M	$148.63M	$173.14M	$188.56M	$184.31M	$185.39M	$199.75M
Research & development	$23.35M	$24.93M	$26.18M	$29.04M	$28.65M	$26.93M	$22.11M	$29.37M	$27.83M	$39.44M	$29.46M	$25.76M
Selling, general & admin	$81.28M	$86.52M	$85.90M	$69.75M	$79.41M	$89.94M	$93.55M	$179.68M	$122.39M	$125.17M	$133.64M	$128.06M
Operating income	-$996.00K	-$3.15M	$22.57M	$40.84M	$21.41M	-$10.26M	$12.14M	-$60.23M	-$3.94M	-$8.33M	-$57.96M	$21.18M
Interest expense	$0	$0	$0	$0	$0	—	$0	$0	$0	—	$2.31M	$718.00K
Pre-tax income	$990.00K	$243.00K	$26.30M	$44.94M	$26.38M	-$5.83M	$16.67M	-$57.95M	-$1.91M	-$5.95M	-$57.65M	$22.71M
Income tax	-$185.00K	$119.00K	$6.39M	$6.45M	$11.05M	$6.00M	-$5.83M	-$12.84M	$2.19M	-$3.66M	$723.00K	$1.80M
Net income	$1.18M	$124.00K	$19.92M	$38.50M	$15.33M	-$11.83M	$22.50M	-$45.12M	-$4.11M	-$2.29M	-$58.37M	$20.91M
EBITDA	$20.68M	$17.60M	$43.29M	$60.95M	$40.25M	$10.13M	$33.50M	-$35.42M	$21.08M	$17.80M	-$32.22M	$44.81M
EPS (basic)	$0.02	$0.00	$0.36	$0.70	$0.28	$-0.21	$0.40	$-0.80	$-0.07	$-0.04	$-1.01	$0.36
EPS (diluted)	$0.02	$0.00	$0.36	$0.69	$0.27	$-0.21	$0.40	$-0.80	$-0.07	$-0.04	$-1.01	$0.35
Diluted shares	-68.09K	55.63M	55.72M	56.02M	167.35K	55.86M	56.64M	56.55M	317.22K	57.65M	58.07M	59.47M
Gross margin	88.1%	88.6%	89.4%	90.0%	85.0%	89.5%	89.8%	90.1%	89.1%	88.7%	84.6%	88.1%
Operating margin	-0.6%	-2.2%	13.4%	23.2%	12.3%	-6.8%	7.3%	-31.4%	-1.9%	-4.0%	-26.5%	9.3%
Net margin	0.7%	0.1%	11.8%	21.9%	8.8%	-7.9%	13.6%	-23.5%	-1.9%	-1.1%	-26.6%	9.2%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$75.05M	$63.40M	$52.09M	$31.67M	$69.33M	$115.85M	$144.71M	$151.37M	$128.45M	$184.87M	$179.95M	$175.88M
Receivables	$144.16M	$147.73M	$152.49M	$145.41M	$142.08M	$145.64M	$140.83M	$171.25M	$187.80M	$182.18M	$211.66M	$214.71M
Inventory	$77.41M	$75.08M	$68.16M	$63.98M	$54.29M	$49.42M	$44.02M	$107.10M	$112.48M	$110.77M	$107.03M	$113.24M
Total current assets	$493.11M	$544.32M	$591.00M	$640.00M	$686.07M	$687.58M	$738.87M	$593.89M	$644.18M	$731.58M	$723.50M	$711.22M
Goodwill	$117.02M	$117.02M	$117.02M	$117.02M	$117.02M	$117.02M	$117.02M	$119.08M	$124.88M	$120.67M	$119.43M	$119.43M
Total assets	$1.28B	$1.30B	$1.32B	$1.34B	$1.37B	$1.35B	$1.38B	$1.42B	$1.45B	$1.50B	$1.43B	$1.40B
Total current liabilities	$290.20M	$314.55M	$308.66M	$291.51M	$292.40M	$281.77M	$286.36M	$330.63M	$338.17M	$373.93M	$347.38M	$285.40M
Total liabilities	$356.16M	$374.92M	$358.38M	$335.55M	$332.34M	$316.58M	$318.50M	$370.09M	$390.93M	$423.92M	$396.88M	$335.21M
Shareholders' equity	$921.52M	$929.17M	$957.45M	$1.01B	$1.04B	$1.03B	$1.06B	$1.05B	$1.06B	$1.08B	$1.03B	$1.06B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$44.96M	$38.40M	$35.62M	$53.52M	$44.41M	$30.60M	$58.53M	-$61.66M	$19.86M	$66.52M	-$4.81M	$6.61M
Capital expenditures	-$36.00K	$248.00K	$64.00K	$200.00K	$213.00K	$327.00K	$455.00K	$129.00K	$427.00K	$0	$568.00K	$230.00K
Free cash flow	$44.92M	$38.15M	$35.56M	$53.32M	$44.19M	$30.27M	$58.08M	-$61.79M	$19.43M	$66.52M	-$5.38M	$6.38M
Investing cash flow	-$65.98M	-$51.62M	-$48.59M	-$77.01M	-$12.64M	$37.32M	-$30.61M	$48.71M	-$51.31M	-$19.22M	$7.09M	$7.72M
Financing cash flow	$1.09M	$1.57M	$1.66M	$3.08M	$5.89M	-$21.40M	$935.00K	$21.07M	$8.53M	$9.12M	-$7.20M	-$18.39M
Stock-based compensation	$6.45M	$5.90M	$6.55M	$7.67M	$7.63M	$8.07M	$7.51M	$7.83M	$9.65M	$8.48M	$8.64M	$8.93M
Depreciation & amortization	$21.68M	$20.75M	$20.72M	$20.10M	$18.84M	$20.38M	$21.36M	$24.81M	$25.02M	$26.13M	$25.75M	$23.63M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.